Cargando…

Identification of New Biomarker for Prediction of Hepatocellular Carcinoma Development in Early-Stage Cirrhosis Patients

BACKGROUND: Liver cirrhosis is one of the major drivers of hepatocellular carcinoma (HCC). In the present study, we aimed to identify and validate new biomarker for early prediction of HCC development in early-stage cirrhosis patients. METHODS: mRNA expression and clinical parameters of GSE63898, GS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Gang, Li, Yongqiang, Chen, Wenji, Tang, Wenjuan, Shou, Diwen, Luo, Qingling, Chen, Huiting, Zhou, Yongjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318773/ https://www.ncbi.nlm.nih.gov/pubmed/34335764 http://dx.doi.org/10.1155/2021/9949492

Ejemplares similares

CpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer Patients
por: Ning, Gang, et al.
Publicado: (2021)

Engineering siRNA-loaded and RGDfC-targeted selenium nanoparticles for highly efficient silencing of DCBLD2 gene for colorectal cancer treatment
por: Huang, Hongli, et al.
Publicado: (2023)

Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy
por: Huang, Chen, et al.
Publicado: (2023)

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
por: Kim, Da Jung, et al.
Publicado: (2019)

Novel breath biomarkers identification for early detection of hepatocellular carcinoma and cirrhosis using ML tools and GCMS
por: Ain Nazir, Noor ul, et al.
Publicado: (2023)

Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report
por: Huang, Hongli, et al.
Publicado: (2019)

Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
por: Zhang, Huarong, et al.
Publicado: (2023)

Applying NGS Data to Find Evolutionary Network Biomarkers from the Early and Late Stages of Hepatocellular Carcinoma
por: Wong, Yung-Hao, et al.
Publicado: (2015)

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)

A Potential Serum N-glycan Biomarker for Hepatitis C Virus-Related Early-Stage Hepatocellular Carcinoma with Liver Cirrhosis
por: Higashi, Mikito, et al.
Publicado: (2020)

Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy
por: Wang, Changbing, et al.
Publicado: (2020)

Prognostic Analysis and Biomarkers Identification of Immune Infiltration in Early and Late Stage Hepatocellular Carcinoma Based on TCGA Data
por: Jiang, Wenying, et al.
Publicado: (2023)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Novel extracellular RNA biomarkers for early stage hepatocellular cancer
por: Gondaliya, Piyush, et al.
Publicado: (2021)

Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection
por: Di Poto, Cristina, et al.
Publicado: (2018)

Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol
por: Yamada, Masayoshi, et al.
Publicado: (2011)

Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
por: Gan, Xiaoning, et al.
Publicado: (2020)

Protective role of melatonin in early‐stage and end‐stage liver cirrhosis
por: Hu, Chenxia, et al.
Publicado: (2019)

Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology
por: Zhao, Dandan, et al.
Publicado: (2022)

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
por: LIU, ZHIKUN, et al.
Publicado: (2013)

Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features
por: Ribeiro, Osmar Damasceno, et al.
Publicado: (2016)

A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma
por: Pocino, Krizia, et al.
Publicado: (2021)

Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
por: Chávez-López, María de Guadalupe, et al.
Publicado: (2016)

Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis
por: Wu, Yuexin, et al.
Publicado: (2021)

A novel index for staging hepatitis B related liver cirrhosis in patients with hepatocellular carcinoma
por: Wu, Juanhua, et al.
Publicado: (2021)

LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis
por: Pan, Hong Y., et al.
Publicado: (2021)

Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma
por: Li, Ling, et al.
Publicado: (2019)

Associating microwave ablation and portal vein ligation for staged hepatectomy for the treatment of huge hepatocellular carcinoma with cirrhosis
por: Chen, Jian-Xun, et al.
Publicado: (2016)

Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis
por: Ferrín, Gustavo, et al.
Publicado: (2015)

Identification of early biomarkers in a rabbit model of primary Candida pneumonia
por: Lu, Gang, et al.
Publicado: (2019)

Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data
por: Zeng, Zhili, et al.
Publicado: (2020)

Novel Approaches to Identification of Biomarkers for Detection of Early Stage Cancer
por: Kiviat, Nancy B., et al.
Publicado: (2002)

Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early Hepatocellular carcinoma in patients with cirrhosis
por: Guo, Yantong, et al.
Publicado: (2012)

Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2020)

A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
por: Luo, Ping, et al.
Publicado: (2018)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening
por: Simão, Adélia, et al.
Publicado: (2015)

Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis
por: Abdel-Hafiz, Samah Mamdouh, et al.
Publicado: (2018)

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
por: Oh, Sooyeon, et al.
Publicado: (2020)

H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro
por: Luo, Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_23nuca2mqmud5vpu1r8bt7gd7q